| Literature DB >> 32290434 |
Sonika Garcia-Ribera1,2, Montse Amat-Bou1,2, Eric Climent3, Marina Llobet1,2, Empar Chenoll3, Raquel Corripio4, Lourdes Ibáñez1,2,5, Marta Ramon-Krauel1,2, Carles Lerin1,2.
Abstract
Prader-Willi syndrome is a rare genetic disorder associated with impaired body composition, hyperphagia, and excessive weight gain. Strict dietary restrictions from an early age is crucial to prevent or delay the early onset of obesity, which is the main driver of comorbidities in these patients. The aim of this study was to identify dietary and gut microbiota components closely linked to weight status of these patients. We studied a cohort of children and adolescents with genetic diagnosis of Prader-Willi syndrome (N = 31), in which we determined adiposity by Dual-energy X-ray absorptiometry (DXA) and dietary composition with 4-day food records. Furthermore, we obtained fecal samples to assess microbiota composition by 16S sequencing. Multivariate regression models showed that body mass index standard deviation score (BMI-SDS) and body fat mass were directly associated with saturated fat intake and meat consumption, and inversely associated with fruit consumption. Furthermore, the gut microbiome from normal weight patients was characterized by higher phylogenetic diversity compared to those overweight or obese, with differential abundance of several genera, including Alistipes, Klebsiella, and Murimonas. Notably, Alistipes abundance was inversely correlated to adiposity, lipid and glucose homeostasis parameters, and meat intake. Our results suggest that limiting meat and increasing fruit intake might be beneficial for body weight management in children and adolescents with Prader-Willi syndrome.Entities:
Keywords: Prader–Willi syndrome; adiposity; childhood obesity; dietary intake; gut microbiota
Mesh:
Substances:
Year: 2020 PMID: 32290434 PMCID: PMC7230364 DOI: 10.3390/nu12041063
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic and metabolic characteristics of participants.
| Variables | All Subjects | NW | OWO | |
|---|---|---|---|---|
| Gender (Females) | 19 (61%) | 5 (42%) | 14 (74%) | 0.075 |
| Age (years) | 12.0 (4.0) | 11.4 (3.9) | 12.4 (4.2) | 0.498 |
| Pre-pubertal status | 12 (39%) | 6 (50%) | 6 (32%) | 0.306 |
| Genotype (Deletions) | 18 (58%) | 5 (42%) | 13 (68%) | 0.243 |
| Hyperphagia (HQ-CT Score) | 6.8 (6.0) | 7.3 (7.4) | 6.6 (5.1) | 0.787 |
| Physical activity (>2 h/week) | 17 (55%) | 8 (67%) | 9 (47%) | 0.290 |
| Growth hormone therapy | 30 (97%) | 12 (100%) | 18 (95%) | 0.317 |
| Metformin therapy | 8 (26%) | 1 (8%) | 7 (37%) | 0.061 |
| BMI-SDS | 1.51 (1.38) | 0.22 (0.55) | 2.32 (1.09) |
|
| Body fat mass (%) | 43.2 (8.4) | 35.9 (3.9) | 47.9 (7.0) |
|
| Lipid profile | ||||
| Triglycerides (mg/dL) | 70 (25) | 64 (26) | 74 (25) | 0.294 |
| Cholesterol (mg/dL) | 170 (36) | 155 (34) | 179 (35) | 0.069 |
| LDL-cholesterol (mg/dL) | 102 (31) | 88 (30) | 112 (28) |
|
| HDL-cholesterol (mg/dL) | 56 (13) | 55 (13) | 58 (14) | 0.529 |
| Glucose metabolism | ||||
| Glucose (mg/dL) | 87 (9) | 85 (10) | 88 (9) | 0.352 |
| HbA1c (%) | 5.3 (0.2) | 5.2 (0.3) | 5.3 (0.2) | 0.692 |
| Insulin (mU/L) | 12.6 (9.2) | 8.0 (7.2) | 15.6 (9.3) |
|
| HOMA-IR | 2.82 (2.18) | 1.76 (1.62) | 3.49 (2.26) |
|
Data are shown as mean and standard deviation (SD) for continuous variables and n and percentage (%) for categorical variables. a, group differences were assessed with Student’s t-test (continuous variables) or Chi-square test (categorical variables). Bold font represents p < 0.05. HQ-CT, hyperphagia questionnaire for clinical trials; BMI-SDS, body mass index standard deviation score; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance.
Dietary intake analysis of participants.
| Dietary Intake | All Subjects | NW | OWO | |
|---|---|---|---|---|
| Energy Intake (kcal/day) | 1571 (349) | 1525 (308) | 1600 (378) | 0.552 |
| (% RCI) | 80 (22) | 84 (26) | 78 (20) | 0.493 |
| Protein (% kcal) | 17.7 (2.7) | 17.3 (2.7) | 18.0 (2.9) | 0.530 |
| Fat (% kcal) | 32.7 (6.0) | 31.1 (6.1) | 33.7 (5.9) | 0.256 |
| SFA (% kcal) | 9.4 (2.6) | 8.6 (2.7) | 9.9 (2.4) | 0.170 |
| MUFA (% kcal) | 14.9 (2.7) | 14.1 (2.8) | 15.4 (2.6) | 0.198 |
| PUFA (% kcal) | 5.1 (1.3) | 5.2 (1.2) | 5.0 (1.3) | 0.727 |
| Carbohydrate (% kcal) | 46.6 (5.6) | 48.2 (4.6) | 45.5 (6.0) | 0.176 |
| Fiber (g/day) | 23.8 (12.0) | 24.9 (10.0) | 23.1 (13.4) | 0.681 |
MRI, macronutrient recommended intake; NW, normal weight; OWO, overweight and obesity; RCI, recommended caloric intake; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. Data are shown as mean and SD. Group differences were assessed with Student’s t-test.
Food group intake analysis of participants in the study.
| Food Groups | All Subjects | NW | OWO | |
|---|---|---|---|---|
| Grains | 27.6 (7.0) | 25.6 (8.2) | 29.0 (6.1) | 0.235 |
| Legumes | 4.4 (3.6) | 4.4 (4.4) | 4.3 (3.2) | 0.960 |
| Vegetables | 5.4 (2.1) | 6.0 (2.0) | 5.1 (2.1) | 0.245 |
| Fruit | 11.8 (6.5) | 14.6 (5.9) | 10.0 (6.3) |
|
| Dairy | 16.9 (6.6) | 18.4 (8.3) | 16.0 (5.2) | 0.394 |
| Meat | 9.9 (5.8) | 7.0 (3.8) | 11.7 (6.3) |
|
| Fish | 3.6 (1.7) | 3.9 (1.7) | 3.5 (1.8) | 0.499 |
| Eggs | 1.7 (1.2) | 1.8 (1.1) | 1.7 (1.2) | 0.946 |
| Oils and fats | 11.6 (2.6) | 11.9 (3.0) | 11.4 (2.4) | 0.589 |
| Beverages | 1.6 (2.0) | 1.6 (1.9) | 1.7 (1.6) | 0.899 |
NW, normal weight; OWO, overweight and obesity. Food group data are shown as mean and SD of % of total calorie intake. Group differences were assessed with Student’s t-test. Bold font represents p < 0.05.
Associations between dietary variables and adiposity or BMI-SDS.
| Dietary Variables | BMI-SDS | Body Fat Mass (%) | ||
|---|---|---|---|---|
| B (CI 95%) | B (CI 95%) | |||
| Caloric intake (kcal/day) a | 0.00 (0.00 to 0.00) | 0.293 | −0.01 (−0.02 to 0.00) | 0.133 |
| Protein (% kcal) | 0.11 (−0.11 to 0.33) | 0.302 | 0.11 (−1.18 to 1.41) | 0.856 |
| Fat (% kcal) | 0.08 (0.00 to 0.17) | 0.061 | 0.44 (−0.06 to 0.94) | 0.084 |
| SFA (% kcal) |
|
|
|
|
| MUFA (% kcal) | 0.16 (−0.02 to 0.35) | 0.081 | 0.88 (−0.20 to 1.96) | 0.105 |
| PUFA (% kcal) | −0.12 (−0.56 to 0.32) | 0.571 | −1.09 (−3.61 to 1.43) | 0.379 |
| Carbohydrates (% kcal) | − |
| −0.39 (−0.92 to 0.14) | 0.145 |
| Fiber (g/day) | −0.03 (−0.08 to 0.02) | 0.168 | −0.21 (−0.50 to 0.08) | 0.144 |
Linear regression models were adjusted by sex, age, physical activity level, genotype, metformin use, and caloric intake. a, model not adjusted by caloric intake. B, effect size from the multivariate regression model; CI, confidence interval; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. Bold font indicates p < 0.05.
Associations between food group intake and BMI-SDS or adiposity.
| Food Groups | BMI-SDS | Body Fat Mass (%) | ||
|---|---|---|---|---|
| B (CI 95%) | B (CI 95%) | |||
| Grains | 0.03 (−0.04 to 0.11) | 0.360 | 0.19 (−0.25 to 0.63) | 0.375 |
| Legumes | −0.05 (−0.23 to 0.12) | 0.535 | −0.19 (−1.20 to 0.83) | 0.707 |
| Vegetables | −0.22 (−0.48 to 0.04) | 0.098 | −0.64 (−2.21 to 0.93) | 0.406 |
| Fruit | − |
| − |
|
| Dairy | −0.01 (−0.11 to 0.08) | 0.751 | −0.08 (−0.62 to 0.47) | 0.776 |
| Meat |
|
|
|
|
| Fish | −0.12 (−0.46 to 0.21) | 0.459 | −0.95 (−2.86 to 0.97) | 0.318 |
| Eggs | 0.23 (−0.24 to 0.69) | 0.329 | 1.45 (−1.24 to 4.15) | 0.276 |
| Oils and fat | −0.05 (−0.27 to 0.17) | 0.632 | −0.03 (−1.31 to 1.26) | 0.966 |
| Beverages | −0.17 (−0.44 to 0.11) | 0.216 | −0.38 (−2.01 to 1.25) | 0.632 |
Model adjusted by sex, age, physical activity level, genotype, metformin use, and caloric intake. B, effect size from the multivariate regression model; CI, confidence interval. Bold font indicates p < 0.05.
Figure 1Gut microbiota analysis in children and adolescents with Prader–Willi syndrome. (a) Shannon index indicating α-diversity; significance between normal weight (NW; n = 12; green bars) and overweight and obesity (OWO; n = 19; orange bars) groups was assessed with Wilcoxon rank-sum test. (b) Principal coordinate analysis (PCoA) of unweighted UniFrac distances from all subjects (NW depicted as green circles, OWO as orange circles). (c) Fold change for genus with significantly different abundance in NW and OWO patients after Wald test; # indicates Benjamini–Hochberg adjusted p < 0.05. d) Heatmap of Spearman correlation coefficients between genera abundance and physiologic and nutritional variables. *, p < 0.05; **, p < 0.01; ***, p < 0.005. BMI-SDS, body mass index standard deviation score; LDL-Cho, low-density lipoprotein-cholesterol; HDL-Cho, high-density lipoprotein-cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance.